Patients who took popular weight loss drugs were 12 per cent less likely to develop Alzheimer’s disease but were more at risk of arthritic, kidney and pancreatic disorders, according to the largest ever study of the medicines’ widening impact.
根据对减肥药物大范围影响的有史以来最大规模的研究，服用流行减肥药的患者患阿尔茨海默病的可能性降低了12%，但患关节炎、肾脏和胰腺疾病的风险增加了。
您已阅读8%（428字），剩余92%（5005字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。